These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 26309431)
21. Association of Plasma Ghrelin Levels with Insulin Resistance in Type 2 Diabetes Mellitus among Saudi Subjects. Al Qarni AA; Joatar FE; Das N; Awad M; Eltayeb M; Al-Zubair AG; Ali ME; Al Masaud A; Shire AM; Gumaa K; Giha HA Endocrinol Metab (Seoul); 2017 Jun; 32(2):230-240. PubMed ID: 28555463 [TBL] [Abstract][Full Text] [Related]
22. NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. Corona G; Mannucci E; Petrone L; Balercia G; Paggi F; Fisher AD; Lotti F; Chiarini V; Fedele D; Forti G; Maggi M J Sex Med; 2007 Jul; 4(4 Pt 1):1038-45. PubMed ID: 17627748 [TBL] [Abstract][Full Text] [Related]
23. Role of pentraxin-3 in risk assessment of patients with metabolic syndrome. Zlibut A; Bocsan IC; Pop RM; Vesa SC; Bheecarry K; Revnic R; Cojan-Minzat B; Lupu S; Buzoianu AD; Agoston-Coldea L Physiol Int; 2019 Sep; 106(3):283-293. PubMed ID: 31560233 [TBL] [Abstract][Full Text] [Related]
24. Plasma Leptin in Patients at Intermediate to High Cardiovascular Risk With and Without Type 2 Diabetes Mellitus. Montagnana M; Fava C; Targher G; Franchini M; Danese E; Bonafini S; De Cata A; Salvagno GL; Ruzzenente O; Guidi GC; Lippi G J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27470535 [TBL] [Abstract][Full Text] [Related]
25. Visfatin and ghrelin: can they be forthcoming biomarkers or new drug targets for asthma? Toru Ü; Ayada C; Genç O; Şahin S; Arık Ö; Acat M; Bulut İ; Çetinkaya E Int J Clin Exp Med; 2015; 8(4):6257-61. PubMed ID: 26131235 [TBL] [Abstract][Full Text] [Related]
26. Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance. Hetta HF; Ez-Eldeen ME; Mohamed GA; Gaber MA; ElBadre HM; Ahmed EA; Abdellatief RB; Abd-ElBaky RM; Elkady A; Nafee AM; Zahran AM; Ahmad M Egypt J Immunol; 2018 Jun; 25(2):141-151. PubMed ID: 30600957 [TBL] [Abstract][Full Text] [Related]
27. Assessment of serum and salivary visfatin levels in newly diagnosed patients of type-II DM. Jerusha FR; Raghunath V J Oral Maxillofac Pathol; 2023; 27(4):663-667. PubMed ID: 38304514 [TBL] [Abstract][Full Text] [Related]
28. Changes in obestatin gene and GPR39 receptor expression in peripheral tissues of rat models of obesity, type 1 and type 2 diabetes. Kolodziejski PA; Pruszynska-Oszmalek E; Sassek M; Kaczmarek P; Szczepankiewicz D; Billert M; Mackowiak P; Strowski MZ; Nowak KW J Diabetes; 2017 Apr; 9(4):353-361. PubMed ID: 27106635 [TBL] [Abstract][Full Text] [Related]
29. [Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance]. Huo Y; Liu S; Feng J; Li H; Fan Y; Jin Y; Li L Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):584-7. PubMed ID: 25354858 [TBL] [Abstract][Full Text] [Related]
30. Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity. van der Pouw Kraan TC; Chen WJ; Bunck MC; van Raalte DH; van der Zijl NJ; van Genugten RE; van Bloemendaal L; Baggen JM; Serné EH; Diamant M; Horrevoets AJ BMC Med Genomics; 2015 May; 8():20. PubMed ID: 25956355 [TBL] [Abstract][Full Text] [Related]
31. CRP/HDL-C and Monocyte/HDL-C ratios as Predictors of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus. Djesevic M; Hasic S; Lepara O; Jahic R; Kurtovic A; Fajkic A Acta Inform Med; 2023; 31(4):254-259. PubMed ID: 38379696 [TBL] [Abstract][Full Text] [Related]
32. Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study. Stabe C; Vasques AC; Lima MM; Tambascia MA; Pareja JC; Yamanaka A; Geloneze B Clin Endocrinol (Oxf); 2013 Jun; 78(6):874-81. PubMed ID: 22804918 [TBL] [Abstract][Full Text] [Related]
33. The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study. Kittiskulnam P; Thokanit NS; Katavetin P; Susanthitaphong P; Srisawat N; Praditpornsilpa K; Tungsanga K; Eiam-Ong S PLoS One; 2018; 13(5):e0196332. PubMed ID: 29742114 [TBL] [Abstract][Full Text] [Related]
34. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans. Böttcher Y; Teupser D; Enigk B; Berndt J; Klöting N; Schön MR; Thiery J; Blüher M; Stumvoll M; Kovacs P J Clin Endocrinol Metab; 2006 Jul; 91(7):2725-31. PubMed ID: 16636125 [TBL] [Abstract][Full Text] [Related]
35. Study of Visfatin Level in Type 1 Diabetic Children and Adolescents. El Samahi MH; Ismail NA; Matter RM; Selim A; Ibrahim AA; Nabih W Open Access Maced J Med Sci; 2017 Jun; 5(3):299-304. PubMed ID: 28698746 [TBL] [Abstract][Full Text] [Related]
36. [The changes of gastrointestinal hormones GLP-1, PYY and ghrelin in patients with newly diagnosed type 2 diabetes mellitus]. Cui T; Ren Y; Ma H; Liu SF; Zhang XX; Yu HL Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):774-8. PubMed ID: 24325110 [TBL] [Abstract][Full Text] [Related]
37. Potential role of peroxisome proliferator activated receptor gamma activation on serum visfatin and trace elements in high fat diet induced type 2 diabetes mellitus. Tabassum A; Zaidi SNF; Yasmeen K; Mahboob T Life Sci; 2018 Jul; 205():164-175. PubMed ID: 29772226 [TBL] [Abstract][Full Text] [Related]
38. Melatonin and cryptochrome 2 in metabolic syndrome patients with or without diabetes: a cross-sectional study. Al-Sarraf IAK; Kasabri V; Akour A; Naffa R Horm Mol Biol Clin Investig; 2018 May; 35(2):. PubMed ID: 29813030 [TBL] [Abstract][Full Text] [Related]
39. An Evaluation of Acylated Ghrelin and Obestatin Levels in Childhood Obesity and Their Association with Insulin Resistance, Metabolic Syndrome, and Oxidative Stress. Razzaghy-Azar M; Nourbakhsh M; Pourmoteabed A; Nourbakhsh M; Ilbeigi D; Khosravi M J Clin Med; 2016 Jun; 5(7):. PubMed ID: 27348010 [TBL] [Abstract][Full Text] [Related]
40. The association between ghrelin levels and markers of arterial stiffness and inflammatory markers in Saudi subjects with metabolic syndrome. Ali TM; Mehanna OM; El Askary A Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S721-S725. PubMed ID: 28539201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]